Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Therapeutic targets in liver fibrosis.
Fallowfield JA. Fallowfield JA. Am J Physiol Gastrointest Liver Physiol. 2011 May;300(5):G709-15. doi: 10.1152/ajpgi.00451.2010. Epub 2011 Jan 13. Am J Physiol Gastrointest Liver Physiol. 2011. PMID: 21233278 Free article. Review.
Models and mechanisms of fibrosis resolution.
Snowdon VK, Fallowfield JA. Snowdon VK, et al. Among authors: fallowfield ja. Alcohol Clin Exp Res. 2011 May;35(5):794-9. doi: 10.1111/j.1530-0277.2010.01400.x. Epub 2011 Feb 1. Alcohol Clin Exp Res. 2011. PMID: 21284668 Review.
A relaxin-based nanotherapy for liver fibrosis.
Fallowfield JA, Ramachandran P. Fallowfield JA, et al. Nat Nanotechnol. 2021 Apr;16(4):365-366. doi: 10.1038/s41565-020-00832-w. Nat Nanotechnol. 2021. PMID: 33495619 No abstract available.
Emerging synthetic drugs for the treatment of liver cirrhosis.
Fallowfield JA, Jimenez-Ramos M, Robertson A. Fallowfield JA, et al. Expert Opin Emerg Drugs. 2021 Jun;26(2):149-163. doi: 10.1080/14728214.2021.1918099. Epub 2021 Apr 26. Expert Opin Emerg Drugs. 2021. PMID: 33856246 Review.
78 results